Adverse drug reactions associated with ivermectin use for COVID-19 reported in the WHO's pharmacovigilance database

被引：0
|
作者：
Campillo, J. [1 ]
Faillie, J. L. [2 ]
机构：
[1] Univ Montpellier, Dept Med Pharmacol & Toxicol, CHU Montpellier,UMI 233, Inst Rech Dev IRD,Inserm U1175, Montpellier, France
[2] Univ Montpellier, Dept Med Pharmacol & Toxicol, CHU Montpellier, IDESP UMR UA1 Inserm, Montpellier, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2022年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PS-017
引用
收藏
页码：101 / 101
页数：1
相关论文
共 50 条
  • [1] Adverse drug reactions associated with ivermectin use for COVID19 reported in the World Health Organization's pharmacovigilance database
    Campillo, Jeremy T.
    Faillie, Jean-Luc
    [J]. THERAPIE, 2022, 77 (06): : 747 - 749
  • [2] Ivermectin associated adverse events in the treatment and prevention of COVID-19 reported to the FACT pharmacovigilance project
    Farah, Rita
    Kazzi, Ziad
    Brent, Jeffrey
    Burkhart, Keith
    Wax, Paul
    Aldy, Kim
    [J]. CLINICAL TOXICOLOGY, 2022, 60 (08) : 942 - 946
  • [3] Favipiravir Use in COVID-19: Analysis of Suspected Adverse Drug Events Reported in the WHO Database
    Kaur, Rimple Jeet
    Charan, Jaykaran
    Dutta, Siddhartha
    Sharma, Paras
    Bhardwaj, Pankaj
    Sharma, Praveen
    Lugova, Halyna
    Krishnapillai, Ambigga
    Islam, Salequl
    Haque, Mainul
    Misra, Sanjeev
    [J]. INFECTION AND DRUG RESISTANCE, 2020, 13 : 4427 - 4438
  • [4] Tocilizumab in COVID-19: a study of adverse drug events reported in the WHO database
    Charan, Jaykaran
    Dutta, Siddhartha
    Kaur, Rimplejeet
    Bhardwaj, Pankaj
    Sharma, Praveen
    Ambwani, Sneha
    Jahan, Iffat
    Abubakar, Abdullahi Rabiu
    Islam, Salequl
    Hardcastle, Timothy Craig
    Rahman, Nor
    Lugova, Halyna
    Haque, Mainul
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (09) : 1125 - 1136
  • [5] Adverse drug reactions and ivermectin in COVID 19
    Montastruc, Jean-Louis
    [J]. THERAPIE, 2022, 77 (06): : 633 - 634
  • [6] Reported Adverse Drug Reactions Associated With the Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic
    Perez, Justine
    Roustit, Matthieu
    Lepelley, Marion
    Revol, Bruno
    Cracowski, Jean-Luc
    Khouri, Charles
    [J]. ANNALS OF INTERNAL MEDICINE, 2021, 174 (06) : 878 - +
  • [7] ADVERSE DRUG REACTIONS ASSOCIATED TO HYDROXYCHLOROQUINE AND REMDESIVIR IN COVID-19 PATIENTS: ANALYSIS OF REPORTED ADR TO THE PORTUGUESE PHARMACOVIGILANCE SYSTEM
    Ivos, R.
    Ribeiro-Vaz, I
    Polonia, J.
    Silva, A.
    [J]. VALUE IN HEALTH, 2021, 24 : S90 - S90
  • [8] Adverse drug reactions reported with antialdosterones to French Pharmacovigilance database
    Fedrizzi, S.
    Masson, R.
    Humbert, X.
    Gonzalez, C.
    Chenaf, C.
    Atzenhoffer, M.
    Sassier, M.
    Coquerel, A.
    Alexandre, J.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 47 - 47
  • [9] Evaluation of adverse events related to musculoskeletal system reported for COVID-19 vaccines in VigiBase: A WHO pharmacovigilance database
    Kaur, Rimple Jeet
    Charan, Jaykaran
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 1176 - 1177
  • [10] Adverse drug reactions associated with COVID-19 management
    Chavda, Vivek
    Dodiya, Payal
    Apostolopoulos, Vasso
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024,
12345